Skip to main content
Caplight Logo









ConvEyXO

ConvEyXO

Private
CharleroiHealthcare & Life Scienceshttps://conveyxo.com/

Last Round

Seed

Jul 1, 2019

Total Funding Raised

$1.12M

Company Overview

ConvEyXO is a biotechnology company developing a therapeutic portfolio in anti-inflammatory and aging-related diseases built on a proprietary technology platform that harnesses engineered exosomes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

exosome therapeuticsexosomesexosome manufacturingsmall extracellular vesiclessEVsRNA therapeuticsregenerative medicinedrug delivery platforminflammatory disease therapeuticsbiomanufacturing platformosteoarthritis treatmentmicrofluidic loading3D bioreactormiRNA therapeuticsimmortalized cell line

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ConvEyXO Comparables

Compare ConvEyXO with similar companies based on industry and business-model similarity.

ConvEyXO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EXO Biologics
85%
EVerZom
84%
Curexsys GmbH
81%

ConvEyXO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2019

Key People

Founding team and executive leadership

Frédéric Tonglet

CEO

Executive Team

ConvEyXO Investors

Notable investors and investment history

ConvEyXO investors
InvestorRounds
SambrinvestSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Grew 20% QoQ, from 15 to 18 employees.

  • Jan 7, 2026

    Monthly visitors increased 545% MoM.

ConvEyXO Filings

Explore SEC and related filing metadata, where available.

ConvEyXO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ConvEyXO's valuation, stock price, and market status.

Is ConvEyXO a public or private company?

ConvEyXO is a private company.

What is the current stock price of ConvEyXO?

ConvEyXO is a private company with no public stock price. No recent secondary market data is available.

How much is ConvEyXO worth (valuation)?

Valuation information for ConvEyXO is not publicly available.

Can I buy ConvEyXO stock?

ConvEyXO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ConvEyXO's last funding round?

ConvEyXO's most recent funding round was Seed on July 1, 2019.

Who are the main investors in ConvEyXO?

Key investors in ConvEyXO include Sambrinvest.

Will ConvEyXO IPO soon?

No public IPO plans have been announced for ConvEyXO.

How can I track ConvEyXO secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ConvEyXO's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCharleroi
Employee Range13
Year Founded2019
Last FundingJul 1, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?